Log In
Print
BCIQ
Print
Print this Print this
 

Anti-CEA BiTE (MEDI-565) (formerly MT111)

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionBispecific T cell engager (BiTE) targeting the carcinoembryonic antigen (CEA) and CD3
Molecular Target Carcinoembryonic antigen (CEA) ; CD3
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today